Our Solutions
Integrated Cardiovascular Care
Our cardiovascular portfolio offers a comprehensive range of products designed to support interventional cardiology and other cardiovascular procedures across the entire treatment pathway. This portfolio includes solutions from vascular access, lesion assessment and preparation to coronary therapy.
We are the only company amongst the assessed global and Indian peers with a presence across a wide range of cardiovascular interventional products. Furthermore, we are one of the only two Indian companies manufacturing all 3 class of medical devices.
By providing all essential product categories through a single company across multiple brands, we enable physicians and healthcare institutions to source solutions for cardiovascular intervention.
Comprehensive Cardiovascular Solutions
The Intervention Continuum
In interventional cardiology, each successful intervention follows four essential steps:
Access
Reaching the lesion with precision.
Our access portfolio includes vascular accessories, contrast velocity injectors, and PTCA guidewires engineered for deliverability for complex anatomy.
Assess
Understanding the lesion before therapy begins.
Through intravascular imaging and physiology assessment technologies, physicians gain deeper insight into vessel morphology and lesion significance, with the aim to enable informed treatment decisions.
Prepare
Creating the conditions for optimal intervention.
Our lesion preparation portfolio includes intravascular lithotripsy systems for calcium modification in complex arterial lesions, ultra high-pressure balloons for challenging lesion dilation, semi-compliant and non-compliant PTCA balloons for precise pre and post-dilation; and balloon catheters and microcatheters designed to support controlled lesion preparation.
Treat
Where precision matters most.
Our treatment portfolio includes sirolimus-eluting drug-eluting stents with ten-year safety and efficacy data, polymer-free dual-drug-eluting stents, US FDA-approved ridaforolimus-eluting drug-eluting stent platforms, and paclitaxel – coated balloons developed with the intent to support positive clinical outcomes.
